AAV-mediated transcription factor EB (TFEB) gene delivery ameliorates muscle pathology and function in the murine model of Pompe Disease
Abstract Pompe disease (PD) is a metabolic myopathy due to acid alpha-glucosidase deficiency and characterized by extensive glycogen storage and impaired autophagy. We previously showed that modulation of autophagy and lysosomal exocytosis by overexpression of the transcription factor EB (TFEB) gene...
Enregistré dans:
Auteurs principaux: | Francesca Gatto, Barbara Rossi, Antonietta Tarallo, Elena Polishchuk, Roman Polishchuk, Alessandra Carrella, Edoardo Nusco, Filomena Grazia Alvino, Francesca Iacobellis, Elvira De Leonibus, Alberto Auricchio, Graciana Diez-Roux, Andrea Ballabio, Giancarlo Parenti |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2017
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/678d39e7a19b43b9866916b4208c4792 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Correction of oxidative stress enhances enzyme replacement therapy in Pompe disease
par: Antonietta Tarallo, et autres
Publié: (2021) -
mTOR-dependent phosphorylation controls TFEB nuclear export
par: Gennaro Napolitano, et autres
Publié: (2018) -
Structure of human lysosomal acid α-glucosidase–a guide for the treatment of Pompe disease
par: Véronique Roig-Zamboni, et autres
Publié: (2017) -
Molecular study of Pompe disease in Egyptian infants
par: Mona Essawi, et autres
Publié: (2021) -
TFEB regulates murine liver cell fate during development and regeneration
par: Nunzia Pastore, et autres
Publié: (2020)